Selected Publications
Click here to view publications by Dr. Barbara Sherry in PubMed.
Sherry B, Dai WW, Lesser ML, Trachtman H. (2008) Dysregulated chemokine receptor expression and chemokine-mediated cell trafficking in pediatric patients with ESRD. Clin J Am Soc Neph. 3:397-406.
Yurchenko V, Xue Z, Sherry B, Bukrinsky M. (2008) Functional analysis of Leishmania major cyclophilin. Int J Parasitol. 38:633-9.
Wapnir RA, Sherry B, Codipilly CN, Goodwin LO, Vancurova I. (2008) Modulation of Rat Intestinal Nuclear Factor NF-kappa B by Gum Arabic. Dig Dis Sci. 53:80-87.
Laragione T, Yarlett NC, Brenner M, Mello A, Sherry B, Miller EJ, Metz CN, Gulko PS. (2007) The arthritis severity quantitative trait loci (QTL) Cia4 and Cia6 regulate neutrophil migration into inflammatory sites and levels of TNF beta and nitric oxide. J Immunol. 178:2344-2351.
Laragione T, Brenner M, Yarlett NC, Mello A, Miller EJ, Metz CN, Sherry B, Gulko PS. (2007) The arthritis severity quantitative trait locus (QTL) Cia7 regulates neutrophil migration into inflammatory sites. Genes and Immunity. 8:147-153.
Qin, S, Wang H, Yuan R, Li H, Ochani M, Ochani K, Rosas-Ballina M, Czura CJ, Huston JM, Miller E, Lin X, Sherry B, Kuman A, LaRosa G, Newman W, Tracey KJ Yang H. (2006) Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med. 203:1637-1642.
Ghezzi P, Casagrande S, Massignan T, Basso M, Bellacchio E, Mollica L, Biasini E, Tonelli R, Eberini I, Gianazza E, Dai WW, Gratelli M, Salmona M, Sherry B, Bonetto V. (2006) Redox regulation of cyclophilin A by glutathionylation. Proteomics. 6:817-825.
Di Marzio P, Dai WW, Franchin G, Chan AY, Symons M, Sherry B. (2005) Role of Rho family GTPases in CCR1- and CCR5-induced actin reorganization in macrophages. BBRC. 331:909-916.
Pushkarsky T, Yurchenko V, Vanpouille C, Brichacek B, Vaisman I, Hatakeyama S, Nakayama KI, Sherry B, Bukrinsky MI. (2005) Cell surface expression of CD147/EMMPRIN is regulated by cyclophilin 60. J Biol Chem. 280:27866-27871.
Saeed RW, Varma S, Peng-Nemeroff T, Sherry B, Balakhaneh D, Huston J, Tracey KJ, Al-Abed Y, Metz CN. (2005) Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med. 201:1113-1123.
[go back to the top]
Amella CA, Sherry B, Shepp D, Schmidtmayerova H. (2005) Macrophage inflammatory protein 1 alpha inhibits post-entry steps of HIV-1 infection via suppression of intracellular cAMP. J.Virol. 79:5625-5631.
Yurchenko V, Pushkarsky T, Li JH, Dai WW, Sherry B, Bukrinsky M. (2005) Regulation of CD147 cell surface expression: involvement of the proline residue in the CD147 transmembrane domain.
J Biol Chem. 280:17013-17019.
Saeed RW, Varma S, Peng T, Tracey KJ, Sherry B, Metz CN. (2004) Ethanol blocks leukocyte recruitment and endothelial cell activation in vivo and in vitro. J Immunol. 173:6376-6383.
Gross E, Amella CA, Pompucci L, Franchin G, Sherry B, Schmidtmayerova H. (2003) Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV 1 infection. J. Leuk. Biol. 74:781-790.
Di Marzio P, Sherry B, Thomas EK, Franchin G, Schmidtmayerova H, Bukrinsky M. (2003) Beta-Chemokine production in CD40L-stimulated monocyte-derived-macrophages requires activation of MAPK signaling pathway. Cytokine. 23:53-63.
Oyajobi BO, Franchin G, Williams PJ, Pulkrabek D, Gupta A, Munoz S, Grubbs B, Zhao M, Chen D, Sherry B, Mundy GR. (2003) Dual effects of macrophage inflammatory protein 1alpha on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease. Blood. 102:311-319.
Yurchenko V, Zybarth G, O'Connor M, Dai WW, Franchin G, Hao T, Guo H, Hung HC, Toole B, Gallay P, Sherry B, Bukrinsky M (2002) Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J. Biol. Chem. 277:22959-22965.
Pushkarsky T, Zybarth G, Dubrovsky L, Yurchenko V, Tang H, Guo H, Toole B, Sherry B, Bukrinsky M (2001) CD147 facilitates HIV 1 infection by interacting with virus associated cyclophilin A. Proc. Natl. Acad. Sci. USA. 98:6360 6365.
Sherry B, Franchin G. (2000) MIP-1α, MIP-1β. In: Cytokine Reference: A compendium of cytokines and other mediators of host defense. Volume I. Oppenheim J.J. and Feldmann M. (eds.), Academic Press, San Diego, pp. 1171-1215.
[go back to the top]
Sherry B, Schmidtmayerova H, Zybarth G, Dubrovsky L, Raabe T, Bukrinsky M (2000) Nitric oxide regulates MIP-1α expression in primary macrophages and T lymphocytes: Implications for anti-HIV-1 response. Mol Med. 6:542-549.
Franchin G, Zybarth G, Dai WW, Dubrovsk, I, Reiling N, Schmidtmayerova H, Bukrinsky M, Sherry B (2000) Lipopolysaccharide inhibits HIV-1 infection of monocyte-derived macrophages through direct and sustained down-regulation of CC chemokine receptor 5. J. Immunol. 164:2592-2601.
Martiney JA, Sherry B, Metz CN, Espinoza M, Ferrer AS, Calandra T, Broxmeyer HE, Bucala R. (2000) Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: Possible role in the pathogenesis of malarial anemia. Infect. Immun. 68:2259-2267.
Zybarth G, Reiling N, Schmidtmayerova H, Sherry B, Bukrinsky M. (1999) Activation-induced resistance of human macrophages to HIV-1 infection in vitro. J. Immunol. 162:400-406.
Sherry B, Espinoza M, Manogue KR Cerami A. (1998) Induction of the chemokine β peptides, MIP-1α and MIP-1β, by lipopolysaccharide is differentially regulated by immunomodulatory cytokines γ IFN, IL-10, IL-4, and TGF-β. Mol. Med. 4:648-657.
Wang H, Zhang M, Bianchi M, Sherry B, Sama A, Tracey KJ. (1998) Fetuin (α 2-HS-glycoprotein) opsonizes cationic macrophage deactivating molecules. Proc. Natl. Acad. Sci. USA. 95:14429-14434.
Sherry B, Zybarth G, Alfano M, Dubrovsky L, Mitchell R, Rich D, Ulrich P, Bucala R, Cerami A, Bukrinsky M. (1998) Role of cyclophilin A in the uptake of HIV-1 by macrophages and T lymphocytes. Proc. Natl. Acad. Sci. USA. 95:1758-1763.
Wu X, Dolecki GJ, Sherry B, Zagorski J, Lefkowith JB. (1997) Chemokines are expressed in a myeloid cell-dependent fashion and mediate distinct functions in immune complex glomerulonephritis in rat. J. Immunol. 158:3917-3924.
Zhang M, Caragine T, Wang H, Cohen PS, Botchkina G, Soda K, Bianchi M, Ulrich P, Cerami A, Sherry B, Tracey KJ. (1997) Spermine inhibits pro-inflammatory cytokine synthesis in human mononuclear cells: A counter-regulatory mechanism that restrains the immune system. J. Exp. Med. 185:1759-1768.
Maric M, Chen L, Sherry B, Liu Y. (1997) A mechanism for selective recruitment of CD8 T cells inot B7-1-transfected plasmacytoma: Role of macrophage inflammatory protein-1α. J. Immunol. 159:360-368.
Schmidtmayerova H, Sherry B, Bukrinsky M. (1996) Differential effect of β chemokines on HIV-1 replication in T lymphocytes and monocytes. Nature. 382:767.
Karp CL, Wysocka M, Wahl LM, Ahearn JM, Cuomo PJ, Sherry B, Trinchieri G, Griffin DE. (1996) Mechanism of suppression of cell-mediated immunity by measles virus. Science. 273:228-231.
Schmidtmayerova H, Nottet HS, Nuovo LM, Raabe G, Flanagan T, Dubrovsky CR, Gendelman L, Cerami A, Bukrinsky M, Sherry B. (1996) HIV 1 infection alters chemokine β peptide expression in human monocytes: Implications for recruitment of leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. USA. 93:700-704.
[go back to the top]
Sherry B, Alava G, Tracey KJ, Martiney J, Cerami A, Slater AFG. (1995) The malaria-specific metabolite hemozoin mediates the release of several potent endogenous pyrogens (TNF, MIP 1α, and MIP 1β) in vitro, and altered thermoregulation in vivo. J. Inflammation. 45:85-86.
Sherry B, Cerami A. (1993) Macrophage inflammatory protein-1 Cytokines of the Lung, Kelly, J. (ed.) Marcel Dekker, Inc., New York 61:369-380.
Widmer U, Manogue KR, Cerami A, Sherry B. (1993) Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP) 2, MIP 1α, and MIP 1β members of the chemokine superfamily of pro-inflammatory cytokines. J. Immunol. 150:4996-5012.
Broxmeyer HE, Sherry B, Cooper S, Lu L, Maze R, Beckmann MP, Cerami A, Ralph P. (1993) Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression. J. Immunol. 150:3448-3458.
Maze R, Sherry B, Kwon BS, Cerami A, Broxmeyer HE. (1992) Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1 α. J. Immunol. 149:1004 1009.
Sherry B, Yarlett N, Strupp A, Cerami A. (1992) Identification of cyclophilin as a pro-inflammatory secretory product of LPS-activated macrophages. Proc. Natl. Acad. Sci. USA. 89:3511-3515.
Fahey TJ III, Tracey KJ, Tekamp-Olson P, Cousens LS, Jones WG, Shires GT, Cerami A, Sherry B. (1992) Macrophage inflammatory protein 1 modulates macrophage function. J. Immunol. 148:2764-2769.
Broxmeyer HE, Sherry B, Cooper S, Ruscetti FW, Williams DE, Arosio P, Kwon BS, Cerami A. (1991) Macrophage inflammatory protein (MIP) 1b abrogates the capacity of MIP 1a to suppress myeloid progenitor cell growth. J. Immunol. 147:2586-2594.
Widmer U, Yang Z, van Deventer S, Manogue KR, Sherry B, Cerami A. (1991) Genomic structure of murine macrophage inflammatory protein (MIP)-1α: Conservation of potential regulatory sequences with the human homolog LD78. J. Immunol. 146:4031-4040.
Sherry B and Cerami A. (1991) Small cytokine superfamily. Curr. Opinion Immunol. 3:56-60.
Fahey TJ III, Sherry B, Tracey KJ, van Deventer S, Jones WG II, Minei JP, Morgello S, Shires GT, and Cerami A (1990) Cytokine production in a model of wound healing: The appearance of MIP-1, MIP-2, Cachectin/TNF and IL-1. Cytokine. 2:92-99.
Sherry B, Jue D-M, Zentella A, and Cerami A. (1990) Characterization of high molecular weight glycosylated forms of murine cachectin/TNF. BBRC. 173:1072-1078.
Jue D-M, Sherry B, Luedke C, Manogue K, and Cerami A. (1990) Processing of newly-synthesized cachectin/tumor necrosis factor in endotoxin-stimulated macrophages. Biochemistry. 29:8371-8377.
Broxmeyer HE, Sherry B, Lu L, Cooper S, Oh K-O, Olson P-T, Kwon BS, and Cerami A. (1990) Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood. 76:1110-1116.
Tekamp-Olson P, Gallegos C, Bauer D, McClain J, Sherry B, Fabre M, van Deventer S, and Cerami A. (1990) Cloning and characterization of cDNAs for murine macrophage inflammatory protein-2 and its human homologs. J. Exp. Med. 172:911-919.
Broxmeyer HE, Sherry B, Lu L, Cooper S, Carow C, Wolpe SD, and Cerami A. (1989) Myelopoietic enhancing effects of murine macrophage inflammatory proteins 1 and 2 on colony formation In vitro by murine and human bone marrow granulocyte/macrophage progenitor cells. J. Exp. Med. 170:1583-1593.
[go back to the top]
Sherry BA, Gelin F, Fong Y, Marano M, Wei H, Cerami A, and Lowry SF, Lundholm KG, Moldawer LL. (1989) Anti-cachectin/tumor necrosis factor-α antibodies attenuate the development of cachexia in two murine transplantable tumor models. FASEB J. 3:1956-1962.
Davatelis G, Wolpe SD, Sherry B, Dayer J-M, Chicheportiche R, and Cerami A. (1989) Macrophage inflammatory protein-1 (MIP-1) is an endogenous pyrogen that acts independently of prostaglandin synthesis. Science. 243:1066-1068.
Wolpe SD, Sherry B, Juers D, Davatelis G, Yurt RW, and Cerami A. (1989) Identification and characterization of macrophage inflammatory protein 2. Proc. Natl. Acad. Sci. USA. 86:612-616.
Sherry B, Tekamp-Olson P, Gallegos C, Bauer D, Davatelis G, Wolpe SD, Masiarz F, Coit D, and Cerami A. (1988) Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1ß. J. Exp. Med. 168:2251-2259.
Sherry B, and Cerami A. (1988) Cachectin/tumor necrosis factor exerts endocrine, paracrine and autocrine control of inflammatory responses. J. Cell Biol. 107:1269-1277.
Wolpe SD, Davatelis G, Sherry B, Beutler B, Hesse DG, Nguyen HT, Moldawer LL, Nathan CF, Lowry SF, and Cerami A. (1988) Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J. Exp. Med. 167:570-581.
[go back to the top]